
Cencora
United States"Creating healthier futures"
About
Cencora operates as one of the three dominant pharmaceutical wholesalers in the United States, managing the complex logistics that move medications from manufacturers to hospitals and pharmacies. The company traces its modern corporate origins to January 1, 2001, when AmeriSource Pharmaceutical Group merged with Bergen Brunswig to form AmerisourceBergen. In June 2023, the organization dropped the legacy name for Cencora to reflect a strategic pivot toward broader healthcare solutions beyond traditional drug distribution.
Headquartered in Chesterbrook, Pennsylvania, the firm employs over 51,000 people globally who work to ensure medication availability across retail chains, long-term care facilities, and specialized clinics. Steven H. Collis has led the company as Chairman and CEO since 2009, overseeing expansions into specialty pharmacy services and veterinary medicine through its Covetrus division. While consumers rarely see the brand on their prescriptions, Cencora supplies major retailers like Walgreens and handles billions of doses annually.
Products & Sub-brands
Frequently Asked Questions
Who owns Cencora?
Who is the CEO of Cencora?
Is Cencora still in business?
What is Cencora worth?
Does Cencora own Covetrus?
Keywords
Sources
Company Info
- Founded
- January 1, 2001
- CEO
- Steven H. Collis
- Headquarters
- Chesterbrook, Pennsylvania, United States
- Industry
- Pharmaceutical distribution and healthcare solutions
- Parent Company
- Publicly traded (NYSE: COR)
- Employees
- 51000
- Rebranded
- June 2023
- Stock Ticker
- COR
- Exchange
- New York Stock Exchange
- CEO Since
- 2009
- Key Subsidiary
- Covetrus
Official Website
www.cencora.com/
Join the community
fans discussing